P1486: TRIALS IN PROGRESS: THE THRIVE STUDIES EVALUATING THE EFFICACY, SAFETY, AND LONG-TERM TREATMENT WITH INCLACUMAB, A P-SELECTIN INHIBITOR, IN PATIENTS WITH SICKLE CELL DISEASE

P1486: TRIALS IN PROGRESS: THE THRIVE STUDIES EVALUATING THE EFFICACY, SAFETY, AND LONG-TERM TREATMENT WITH INCLACUMAB, A P-SELECTIN INHIBITOR, IN PATIENTS WITH SICKLE CELL DISEASE

Bibliographic Details
Main Authors:	B. Andemariam, A. Inati, R. Colombatti, C. Minniti, C. Brown, M. Hottmann, S. Gray, C. Hoppe, M. Davis, P. Yue
Format:	Article
Language:	English
Published:	Wiley 2022-06-01
Series:	HemaSphere
Online Access:	http://journals.lww.com/10.1097/01.HS9.0000848800.77383.3d

Similar Items

5572697 TRIALS IN PROGRESS: THE THRIVE STUDIES EVALUATING THE EFFICACY, SAFETY, AND LONG-TERM TREATMENT WITH INCLACUMAB, A P-SELECTIN INHIBITOR, IN PATIENTS WITH SICKLE CELL DISEASE
by: B. Andemariam, et al.
Published: (2023-04-01)

S107: P-SELECTIN INHIBITOR INCLACUMAB REDUCES CELL ADHESION IN AN IN-VITRO ASSAYS SHOWING POTENTIAL FOR PREVENTION OF VASO-OCCLUSION EVENTS IN SICKLE CELL DISEASE
by: M Tarasev, et al.
Published: (2022-01-01)

S119: PRELIMINARY RESULTS OF A PHASE 1 STUDY IN HEALTHY SUBJECTS ADMINISTERED INCLACUMAB, A FULLY HUMAN IGG4 ANTI-P-SELECTIN MONOCLONAL ANTIBODY IN DEVELOPMENT FOR TREATMENT OF SICKLE CELL DISEASE
by: C Mayer, et al.
Published: (2022-01-01)

Effects of the P‐Selectin Antagonist Inclacumab on Myocardial Damage After Percutaneous Coronary Intervention According to Timing of Infusion: Insights From the SELECT‐ACS Trial
by: Barbara E. Stähli, et al.
Published: (2016-10-01)

E- and P-Selectin: Differences, Similarities and Implications for the Design of P-Selectin Antagonists
by: Florian P. C. Binder, et al.
Published: (2011-04-01)

Bromelain decreases neutrophil interactions with P-selectin, but not E-selectin, in vitro by proteolytic cleavage of P-selectin glycoprotein ligand-1.
by: Jessica M Banks, et al.
Published: (2013-01-01)

P-010: TREATMENTS FOR SICKLE CELL DISEASE (SCD) AND THE HEALTHCARE PROFESSIONAL (HCP)–PATIENT RELATIONSHIP: HCP OPINIONS FROM THE INTERNATIONAL SICKLE CELL WORLD ASSESSMENT SURVEY (SWAY)
by: ANDEMARIAM B., et al.
Published: (2022-08-01)

P1467: HEALTHCARE PROFESSIONALS (HCP) OPINIONS ON TREATMENTS FOR SICKLE CELL DISEASE (SCD) AND THE HCP–PATIENT RELATIONSHIP: RESULTS FROM THE INTERNATIONAL SICKLE CELL WORLD ASSESSMENT SURVEY (SWAY)
by: B. Andemariam, et al.
Published: (2022-06-01)

Systematic Review and Meta-Analysis of the Effect of Statins on Circulating E-Selectin, L-Selectin, and P-Selectin
by: Angelo Zinellu, et al.
Published: (2021-11-01)

P1429: IN VITRO COMPARISON OF THE EFFECTS OF INCLACUMAB VS CRIZANLIZUMAB ON REDUCING ENDOTHELIAL ADHESION OF RED BLOOD CELLS IN STANDARDIZED MICROFLUIDIC PLATFORM
by: Chiara Federici, et al.
Published: (2023-08-01)

P-Selectin Blockade in the Treatment of Painful Vaso-Occlusive Crises in Sickle Cell Disease: A Spotlight on Crizanlizumab
by: Karki NR, et al.
Published: (2021-03-01)

Phase 1 study of the E-selectin inhibitor GMI 1070 in patients with sickle cell anemia.
by: Ted Wun, et al.
Published: (2014-01-01)

The vimentin rod domain blocks P-selectin-P-selectin glycoprotein ligand 1 interactions to attenuate leukocyte adhesion to inflamed endothelium.
by: Fong Wilson Lam, et al.
Published: (2020-01-01)

Design and development of ICCA as a dual inhibitor of GPIIb/IIIa and P-selectin receptors
by: Chen H, et al.
Published: (2018-07-01)

Correction: Phase 1 Study of the E-Selectin Inhibitor GMI 1070 in Patients with Sickle Cell Anemia
Published: (2014-01-01)

Correction: Phase 1 Study of the E-Selectin Inhibitor GMI 1070 in Patients with Sickle Cell Anemia.
Published: (2014-01-01)

P-selectin glycoprotein ligand-1 forms dimeric interactions with E-selectin but monomeric interactions with L-selectin on cell surfaces.
by: Yan Zhang, et al.
Published: (2013-01-01)

A cell-extrinsic ligand acquired by activated T cells in lymph node can bridge L-selectin and P-selectin.
by: Douglas A Carlow, et al.
Published: (2018-01-01)

Glycosylation inhibitors efficiently inhibit P-selectin-mediated cell adhesion to endothelial cells.
by: Pushpankur Ghoshal, et al.
Published: (2014-01-01)

A distinct profile of six soluble adhesion molecules (ICAM-1, ICAM-3, VCAM-1, E-selectin, L-selectin and P-selectin) in rheumatoid arthritis.
by: Littler, A, et al.
Published: (1997)

P-059: TRIAL IN PROGRESS: THE RANDOMIZED, DOUBLE-BLIND, MULTICENTER, PLACEBO-CONTROLLED PHASE 3 RESOLVE TRIAL INVESTIGATING THE EFFICACY OF VOXELOTOR WITH STANDARD OF CARE IN THE RESOLUTION OF LEG ULCERS IN PATIENTS WITH SICKLE CELL DISEASE
by: MINNITI C., et al.
Published: (2022-08-01)

Celestina’s Scandal: Magic and Primitive Accumulation in Holocaust Spain (1486-1507)
by: Víctor M. Pueyo Zoco
Published: (2019-10-01)

P-selectin levels in women with endometriosis and non-endometriosis
by: Tonny Simarmata
Published: (2017-07-01)

PROGNOSTIC VALUE OF P-SELECTIN IN PATIENTS WITH STABLE ANGINA PECTORIS
by: Khvysiuk M. O., et al.
Published: (2018-07-01)

S131: REGIONAL ASSESSMENT OF THE EXPERIENCES OF HEALTHCARE PROFESSIONALS (HCPS) TREATING PATIENTS WITH SICKLE CELL DISEASE (SCD): THE INTERNATIONAL SICKLE CELL WORLD ASSESSMENT SURVEY (SWAY)
by: I Osunkwo, et al.
Published: (2022-01-01)

The association of cell adhesion molecules and selectins (VCAM-1, ICAM-1, E-selectin, L-selectin, and P-selectin) with microvascular complications in patients with type 2 diabetes: A follow-up study
by: Khalid Siddiqui, et al.
Published: (2023-02-01)

P-selectin expression tracks cerebral atrophy in Mexican-Americans
by: Kochunov, P, et al.
Published: (2012)

Lack of influence of the COX inhibitors metamizol and diclofenac on platelet GPIIb/IIIa and P-selectin expression <it>in vitro</it>
by: Gröschel Werner, et al.
Published: (2004-04-01)

A role for P-selectin and complement in the pathological sequelae of germinal matrix hemorrhage
by: Devin Hatchell, et al.
Published: (2023-06-01)

Raised soluble P-selectin moderately accelerates atherosclerotic plaque progression.
by: Kevin J Woollard, et al.
Published: (2014-01-01)

P1485: A MULTICENTER, RETROSPECTIVE STUDY ON REAL-WORLD EXPERIENCE OF PATIENTS WITH SICKLE CELL DISEASE TREATED WITH VOXELOTOR
by: B. Andemariam, et al.
Published: (2022-06-01)

The Role of P-Selectin in COVID-19 Coagulopathy: An Updated Review
by: Chiara Agrati, et al.
Published: (2021-07-01)

P-selectin expression tracks cerebral atrophy in Mexican-Americans
by: Peter eKochunov, et al.
Published: (2012-05-01)

Sulfated Hexasaccharides Attenuate Metastasis by Inhibition of P-selectin and Heparanase
by: Lubor Borsig, et al.
Published: (2011-05-01)

Value of P-selectin in the prognosis of cardiovascular events in patients with multiple myeloma
by: M. O. Panasenko, et al.
Published: (2022-08-01)

Plasma substance P and soluble P-selectin as biomarkers of β-thalassemia induced hypercoagulability
by: Samia A. Ebeid, et al.
Published: (2014-06-01)

P129: NARRATING SICKLE CELL DISEASE: THE EXPERIENCES OF PATIENTS AND CARGIVERS
by: L De Franceschi, et al.
Published: (2022-01-01)

5559749 A MULTICENTER, RETROSPECTIVE STUDY ON REAL-WORLD EXPERIENCE OF PATIENTS WITH SICKLE CELL DISEASE TREATED WITH VOXELOTOR
by: B. Andemariam, et al.
Published: (2023-04-01)

Soluble P- and E-selectin levels as determinants of vaso-occlusive crises among sickle cell anemia patients in a tertiary hospital Northwestern Nigeria
by: Sani Awwalu, et al.
Published: (2020-01-01)

Regulation and migratory role of P-selectin ligands during intestinal inflammation.
by: Ute Hoffmann, et al.
Published: (2013-01-01)